To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults | MicrobiomeTrials← Back to trialsNCT05805826
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2023-03-23Est. Completion: 2031-06-19
Enrollment target: 936 participants Locations- HOPE Research Institute, Phoenix, Arizona, United States
- Anaheim Clinical Trials, LLC, Anaheim, California, United States
- Alliance for Multispecialty Research, LLC, Doral, Florida, United States
- Indago Research & Health Center, Inc, Hialeah, Florida, United States
- Research Centers of America, Hollywood, Florida, United States
- Miami Clinical Research, Miami, Florida, United States
- New Horizon Research Center, Miami, Florida, United States
- Charisma Medical and Research Center, Miami Lakes, Florida, United States
- Private Practice - Dr. Hector Fabregas, Pembroke Pines, Florida, United States
- DBC Research USA, Pembroke Pines, Florida, United States
- BRCR Medical Center Inc., Plantation, Florida, United States
- Clinical Research Trials of Florida, Tampa, Florida, United States
- Great Lakes Clinical Trials - Ravenswood, Chicago, Illinois, United States
- Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States
- Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Washington University, St Louis, Missouri, United States
- NYU Langone Health, New York, New York, United States
- Rochester Clinical Research, Inc., Rochester, New York, United States
- Qcare Site Services Inc. d/b/a Avacare, Durham, North Carolina, United States
- CTI Clinical Research Center, Cincinnati, Ohio, United States
- Benchmark Research, Austin, Texas, United States
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Tomball, Texas, United States
Other microbiome trials you might be interested in
Clostridoides Difficile Associated Disease
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile…
Athens, United StatesEst. completion Dec 11, 2028
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
Re-exposure to systemic antibiotics (i.e., antibiotics absorbed into the bloodstream) is common after a Clostridioides d…
Montreal, CanadaEst. completion Oct 1, 2028